All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B Virus Infection-29604477

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	29604477	G145R	S	S	Hepatitis B Virus Infection	I	View
2	29604477	M133T	S	S	Hepatitis B Virus Infection	I	View
3	29604477	N146Q	S	S	Hepatitis B Virus Infection	I	View
4	29604477	C138Y	S	S	Hepatitis B Virus Infection	I	View
5	29604477	C149R	S	S	Hepatitis B Virus Infection	I	View
6	29604477	R169L	S	S	Hepatitis B Virus Infection	I	View
7	29604477	R169P	S	S	Hepatitis B Virus Infection	I	View
8	29604477	D144G	S	S	Hepatitis B Virus Infection	I	View
9	29604477	K141E	S	S	Hepatitis B Virus Infection	I	View
10	29604477	T114R	S	S	Hepatitis B Virus Infection	I	View
11	29604477	T115A	S	S	Hepatitis B Virus Infection	I	View
12	29604477	N146S	S	S	Hepatitis B Virus Infection	I	View
13	29604477	G115N	S	S	Hepatitis B Virus Infection	I	View
14	29604477	G130N	S	S	Hepatitis B Virus Infection	I	View
15	29604477	T115N	S	S	Hepatitis B Virus Infection	I	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.